About Us
Our Company
Our People
Pipeline
Pipeline
MFA011
Partnering
News
About Us
Our Company
Our People
Pipeline
Pipeline
MFA011
Partnering
News
Precise Antibody Engineering
About us
Our Company
Our People
Contact
Home
Our Science
Cytokine-Fusion Antibody
Novel T cell Targets
Precise Antibody Engineering
Partnering with Us
Pipeline
MFA011
MMB101
MMB102
MMB102
Pipeline
News
2026-05-22
MediMabBio Selected for KHIDI Boston C&D Incubation Program
2026-05-01
MediMabBio Selected for KHIDI Global Marketing Support Program
2025-11-10
MediMabBio Presents MFA031 Research at Cytokines 2025
2025-10-24
MediMabBio Secures KRW 25.6 Billion in Series B Funding to Advance Pipeline and Global Partnerships
2025-10-13
MediMabBio Wins 1st Place at Japan’s “Innovation Tiger 2025”
2025-04-25
MediMabBio Presents Promising Preclinical Data on aTIGIT-IL15 Fusion Antibody at AACR 2025
2025-03-20
MediMabBio Selected for “Bio-MPE Alliance Council” by Korea Biotechnology Industry Organization
2024-10-21
MediMabBio Selected for the “Korea-Singapore Technology Exchange and Investment Promotion Forum” Hosted by the Korea Techno-Venture Foundation
2024-08-27
MediMabBio Selected for 2024 Scale-Up TIPS Program
1
2
3
»